Disrupting mechanisms that control cell proliferation, cell size and apoptosis can cause changes in animal and tissue size and contribute to diseases such as cancer. The LATS family of serine/threonine kinases control tissue size by regulating cell proliferation and function as tumor suppressor genes in both Drosophila and mammals. In order to understand the role of lats in size regulation, we performed a genetic modifier screen in Drosophila to identify components of the lats signaling pathway. Mutations in the Drosophila homolog of C-terminal Src kinase (dcsk) were identified as dominant modifiers of both lats gain-of-function and loss-of-function phenotypes. Homozygous dcsk mutants have enlarged tissue phenotypes similar to lats and FACS and immunohistochemistry analysis of these tissues revealed that dcsk also regulates cell proliferation during development. Animals having mutations in both dcsk and lats display cell overproliferation phenotypes more severe than either mutant alone, demonstrating these genes function together in vivo to regulate cell numbers. Furthermore, homozygous dcsk phenotypes can be partially suppressed by overexpression of lats, indicating that lats is a downstream mediator of dcsk function in vivo. Finally, we show that dCSK phosphorylates LATS in vitro at a conserved C-terminal tyrosine residue, which is critical for normal LATS function in vivo. Taken together, these results demonstrate a role for dCSK in regulating cell numbers during development by inhibiting cell proliferation and suggest that lats is one of the mediators of the dcsk phenotype.
Disrupting mechanisms that control cell proliferation, cell size and apoptosis can cause changes in animal and tissue size and contribute to diseases such as cancer. The LATS family of serine/threonine kinases control tissue size by regulating cell proliferation and function as tumor suppressor genes in both Drosophila and mammals. In order to understand the role of lats in size regulation, we performed a genetic modifier screen in Drosophila to identify components of the lats signaling pathway. Mutations in the Drosophila homolog of C-terminal Src kinase (dcsk) were identified as dominant modifiers of both lats gain-of-function and loss-of-function phenotypes. Homozygous dcsk mutants have enlarged tissue phenotypes similar to lats and FACS and immunohistochemistry analysis of these tissues revealed that dcsk also regulates cell proliferation during development. Animals having mutations in both dcsk and lats display cell overproliferation phenotypes more severe than either mutant alone, demonstrating these genes function together in vivo to regulate cell numbers. Furthermore, homozygous dcsk phenotypes can be partially suppressed by overexpression of lats, indicating that lats is a downstream mediator of dcsk function in vivo. Finally, we show that dCSK
Introduction
By screening for mutations that cause overgrowth of mutant cells in mosaic animals, a number of Drosophila genes have been identified that regulate cell proliferation, cell size and apoptosis (Xu et al., 1995; Theodosiou et al., 1998; Goberdhan et al., 1999; Huang et al., 1999a; Ito and Rubin, 1999; Gao et al., 2000; Gao and Pan, 2001; Tapon et al., 2001 Tapon et al., , 2002 . One of the genes we identified in these screens is the lats tumor suppressor gene (also known as warts, Justice et al., 1995; Xu et al., 1995) . Drosophila lats mutants have enlarged tissue and animal phenotypes due to excessive cell proliferation, rather than changes in cell size or cell death (Xu et al., 1995) . Lats belongs to a family of serine/threonine kinases, which are functionally conserved, as demonstrated by the ability of human LATS1 to rescue all defects of Drosophila lats mutants (Tao et al., 1999) . Furthermore, Lats1-deficient mice develop soft tissue sarcomas and ovarian stromal tumors, indicating an important role for mammalian Lats homologs in tumorigenesis (St John et al., 1999) . Although the kinase domain of LATS1 is crucial for its ability to inhibit cell proliferation when it is overexpressed in human cancer cells (Yang et al., 2001; Xia et al., 2002) , it is not clear how cell proliferation is regulated by lats, nor how LATS itself is regulated. Studies in mammalian cell culture have shown that LATS1 associates with a cytoskeleton component, zyxin, as well as the cell cycle regulator, Cdc2 (Tao et al., 1999; Hirota et al., 2000) . However, LATS1 does not phosphorylate Cdc2 or zyxin, and the substrates of Lats are not known.
To dissect further the mechanism by which the lats tumor suppressor gene functions, we have performed a genetic modifier screen in Drosophila to identify genes interacting with lats. We have identified several loci that genetically interact with lats, and present the genetic and molecular characterization of one of the strong interacting loci, the Drosophila homolog of the mammalian C-terminal Src kinase-CSK.
CSK was originally identified due to its ability to phosphorylate a conserved tyrosine residue at the Cterminal tail of the Src family of protein tyrosine kinases (SFKs) . Targeted disruption of Csk in mice causes embryonic lethality with defects in multiple tissues (Imamoto and Soriano, 1993; Nada et al., 1993) . Removing Src in Csk À/À mice partially suppresses the Csk mutant phenotypes, suggesting that CSK has both Src-dependent and -independent functions during development (Thomas et al., 1995) . Indeed, recent studies using SFK-deficient cells show that CSK regulates cellular processes such as G protein-coupled actin organization in a non-SFK-dependent manner (Lowry et al., 2002) . Finally, cellular and biochemical studies suggest that CSK regulates other molecules during development (Autero et al., 1994; Cloutier and Veillette, 1996; Thomas and Brown, 1999) .
In this study, we show that Drosophila csk (dcsk) regulates cell proliferation and tissue size during development. Mutations in dcsk result in enlarged animals and imaginal discs. An examination of the mutant tissue shows that the increase in tissue size is due to excess cells, rather than an increase in cell size. Immunohistological analysis also shows that the increase in cell numbers is due to excess cell proliferation rather than a decrease in cell death. Furthermore, dCsk phosphorylates Lats at a conserved residue and genetic epistasis experiments show that dcsk specifically interacts with the lats tumor suppressor gene in multiple tissues. Thus, we propose that dCsk and Lats function together to regulate tissue size during development by controlling cell proliferation.
Results

Identification of loci that function with the lats tumor suppressor gene
The Lats kinase is an important regulator of cell proliferation and tissue size, although little is known about its regulation or downstream targets. To identify genes acting in lats-mediated processes, a dominant modifier screen was performed with a Drosophila strain overexpressing lats in the developing eye using the pGMR vector (Hay et al., 1994) (Figure 1a ). One copy of GMR-lats causes a small rough eye phenotype (Figure 1c , Methods) that can be modified by changing the copy number of the lats gene. Thus, this sensitivity to Lats protein level suggests that mutations in components of the lats-signaling pathway may modify the GMR-lats eye phenotype. A collection of 2443 independent lethal P-element insertions (Spradling et al., 1999) were individually crossed to a GMR-lats transgenic line and mutations at 10 loci were identified that modified the GMR-lats phenotype (Methods).
One P-element line, dcsk flik was identified as a dominant suppressor of GMR-lats (Figure 1d ). To verify that the transposon insertion was responsible for suppression of the GMR-lats phenotype, we initially tried to revert the mutant chromosome by excising the P-element. This approach proved unsuccessful because the P[w þ ]-element at cytological position 86E16 was defective (see below). Instead, we showed that Df(3R)M-Kx1, a deletion that removes the 86E16 region and fails to complement dcsk flik , also suppresses the GMR-lats phenotype, suggesting that dcsk flik was the genetic lesion responsible for GMR-lats suppression. To obtain strong loss-of-function alleles, 13 dcsk alleles were generated by X-ray mutagenesis of the dcsk flik chromosome. Southern analysis confirmed that the entire dcsk gene, as well as several neighboring transcripts, were deleted in all these alleles. Still, animals carrying dcsk flik over these deletions died at a similar stage as homozygous dcsk flik mutants, suggesting that dcsk flik is a strong or amorphic allele.
The dcsk flik mutation disrupts the Drosophila C-terminal Src kinase
To determine the gene disrupted by the dcsk flik mutation, we isolated more than 20 cDNAs from a third instar eye imaginal disc cDNA library, which correspond to a single transcript, dcsk-L (Figure 2a ). Another transcript with an alternative noncoding 5 0 exon, dcsk-S, was reported by BDGP (LP09923) (Figure 2a) . Analysis of genomic DNA in the dcsk flik mutant revealed a 12 kb insertion containing both a fold back (FB) and P[w þ ]-element as well as a 1.5 kb genomic deletion, 72 bp from the 5 0 end of dcsk-S and in the first intron of dcsk-L (Figure 2a ). To show that the dcsk gene is responsible for the phenotypes associated with the dcsk flik mutation, we introduced a full-length dcsk-L cDNA under the control of heat shock promoter (hs-dcsk). When induced, this hs-dsck was capable of rescuing all observed phenotypes, including lethality, overproliferation, and genetic interaction with lats ( Figure 6k , Methods), demonstrating that dcsk is specifically disrupted by the dcsk flik mutation. Both dcsk transcripts encode the same 723 amino-acid protein, which is closely related to human C-terminal Src kinase, CSK (Figure 2b-d) Okada et al., 1991) . There are two members of the CSK family in mammals, CSK and CHK (CSK homologous kinase), which are related to the Src family of tyrosine kinases (SFKs) (Brown and Cooper, 1996 ; Thomas and Brugge, 1997; Zrihan-Licht et al., 1998; Stamenovic and Coughlin, 1999) . Database searches revealed that dCSK is the only CSK homolog in the Drosophila genome. The dCSK protein is more similar to CSK than CHK ( Figure 2d ) and contains highly conserved SH2 and tyrosine kinase domains, sharing B70% identity with mammalian CSK (Figure 2b , c). However, the region corresponding to the SH3 domain is divergent in dCSK (Figure 2b , c). The kinase domain contains all 11 subdomains found in eucaryotic kinases as well as the tyrosine-specific consensus sequences DLAARN and PIKWTAPE in subdomains VI and VIII, respectively (Hanks and Hunter, 1995) . dCSK is more closely related to the human and mouse CSK proteins than any other SFKs ( Figure 2d ). Furthermore, as a member of the CSK family, dCSK lacks an N-terminal myristylation site and the C-terminal tyrosine present in other SFKs Okada et al., 1991; Zrihan-Licht et al., 1998) . Finally, dCSK specifically phosphorylates the C-terminal tyrosine residue of the Drosophila Src42 protein ( Figure 6b ). Together, these data show that dCSK is the Drosophila homolog of vertebrate CSK.
Regulation of cell proliferation by Drosophila CSK
The genetic interactions between GMR-lats and dcsk mutations suggest that dcsk might also negatively regulate cell proliferation and tissue/animal size during chromosome contains a 12-kb insertion of an FB element and a crippled P-element, and a 1.5-kb genomic deletion in the first intron of dcsk-L, 72 bp away from dcsk-S. Although these molecular disruptions likely affect both transcripts, which is consistent with the strong/amorphic genetic behavior of the dcsk flik allele, it is possible that dcsk flik is not a molecular null. (b) dcsk encodes the Drosophila homolog of human C-terminal Src kinase. Identical amino acids (a.a.) among dCSK and human CSK (hCSK) are shaded. The SH3-like, SH2 and kinase domains are underlined. (c) Schematic representations of the CSK homologs. The a.a. identity between dCSK and hCSK is indicated for each domain. (d) Phylogenetic tree of tyrosine kinases from the CSK, Src, Tec, and Abl families in Drosophila, mouse, and humans. dCSK is more closely related to hCSK and mCSK than other tyrosine kinases development. Indeed, dcsk flik mutants have enlarged animal and tissue phenotypes. At the white prepupal stage, homozygous larvae are 37% larger than wild-type siblings (Figure 3a, b) . Similarly, the mutant eye-antennal imaginal discs increased in size by approximately 140% (Figure 3c, d) , although Elav staining revealed that photoreceptor cell development proceeds normally (Figure 4a, b ; data not shown) (Robinow and White, 1988; Wolff, 1993; Treisman and Heberlein, 1998) .
The enlarged tissue phenotypes could be caused by either an increase in cell size or in cell number. To distinguish between these two possibilities, dcsk flik mutant cells from eye and wing imaginal discs were examined by microscopy and FSC analysis. Compared to wild-type cells, dcsk flik mutant cells are similar in size, suggesting that the enlarged tissue phenotype was not caused by an increase in cell sizes (Figure 4l , data not shown). An increase in cell number could be triggered by either abolishing cell death or elevating cell proliferation. TUNEL staining revealed that dcsk flik mutants have normal levels of cell death relative to wild-type discs (Figure 4i, j) , suggesting that cell death was not the cause of the enlarged tissues. In contrast, BrdU labeling of dcsk flik mutant discs revealed extra S phases in the posterior region of the eye disc (Figure 4c, d) , suggesting that the regulation of cell proliferation was defective (Wolff, 1993; Thomas et al., 1994; Zavitz and Zipursky, 1997) . Upon close examination of these proliferating cells, we found that the extra BrdU staining did not coincide with the differentiated photoreceptor cells, but were interspersed between them (Figure 4e-h) . In wild-type discs, these cells are arrested at G 0 until they are either recruited into the developing ommatidia or removed by apoptosis at later stages (Thomas et al., 1994; Zavitz and Zipursky, 1997) . Thus, cells that should be arrested in the eye disc are still (Figure 4k ). Together, these data suggest that the primary defect that causes the enlarged tissue phenotypes in dcsk mutants is deregulation of cell proliferation.
Lats and dCSK function together to regulate cell numbers in developing tissues
The lats tumor suppressor gene negatively regulates cell numbers in developing tissues by affecting cell proliferation. Given that dcsk also regulates cell proliferation in developing tissues, we analysed genetic interactions between loss-of-function lats and dcsk alleles to determine if these genes function together in regulating cell numbers. Animals with weak lats allelic combinations, such as lats
P1
/lats e27 , are viable and have wing blades that are 11% (Po0.01, n ¼ 10) larger than wild-type wings (Figure 5a, b) . Removing one copy of dcsk further increases the wing size in lats P1 /lats e27 animals by 13% (Po0.01, n ¼ 10) (Figure 5c ). The increase in wing size is due to an increase in cell numbers, as cell density is similar in wild-type, lats P1 /lats e27 and dcskflik, lats P1 / þ , lats e27 wing blades (7.1870.26 Â 10 À3 cells/mm 2 , P40.1) (Figure 5d-f) . Furthermore, 90% of animals transheterozygous for strong lats and dcsk alleles are lethal and the escapers have deformed legs and spontaneous tumors (Figure 5g-i) . Together, these specific interactions demonstrate that lats and dcsk function together, or synergistically, in the control of cell numbers during tissue development.
Drosophila CSK phosphorylates the C-terminus of the Lats kinase
The lethality associated with double heterozygous dcsk/ lats animals is rare and is observed between genes encoding proteins that physically interact with each other (Xu et al., 1990; McCartney et al., 2000) . Previous work in mammalian systems indicates that LATS molecules are phosphoproteins (Tao et al., 1999) . The LATS protein contains a tyrosine near the C-terminus (Y1098), which is surrounded by a motif (PVYV) similar to the phosphorylation site in c-Src (PQYQ) (Figure 6a ), suggesting dCSK could phosphorylate the C-terminal tyrosine in LATS. Furthermore, this motif is conserved in all mammalian LATS homologs ( Figure 6a ). We performed kinase assays using GSTfusion proteins. GST-dCSK phosphorylated GST-LATS, but not GST-LATS Y1098F , which contains a tyrosine to phenylalanine mutation (Y1098F) (Figure 6c ). These results indicate that dCSK specifically phosphorylates the C-terminal tyrosine, but not other tyrosine residues in LATS.
To examine the relevance of the Y1098 residue in normal LATS function in vivo, we introduced a hslatsY1098F transgene into lats mutants. Multiple hs-latsY1098F transgenic lines were tested and were unable to rescue any of the lethality or large tissue phenotypes of lats mutants (Figure 6d , e, Methods), whereas the hs-lats transgene rescues all lats phenotypes under the same conditions (Figure 6g ). These results show that Y1098 is important for full LATS function in vivo, and we propose that phosphorylation of Y1098 by dCSK is required for the normal function of LATS.
The biochemical data suggest that lats could be one of the mediators of the dcsk phenotype in vivo. To test this hypothesis, we overexpressed lats in dcsk flik homozygous mutants, which die at an early pupal stage (Figure 6i ). When an hs-lats transgene was introduced into the dcsk flik mutants, the overproliferation and early pupal lethal phenotypes were partially suppressed (Figure 6j ). The reciprocal experiment was also performed by overexpressing dcsk using the hs-dcsk transgene in lats homozygous animals or in lats tumors in mosaic animals. None of the lats mutant phenotypes was rescued (Figure 6f , data not shown). Taken together, the genetic and biochemical evidence support the notion that dCSK and LATS function together in regulating cell proliferation and tissue size and suggest that LATS is one of the targets of dCSK during development. The mechanisms that regulate tissue size remain largely unknown. However, it is becoming increasingly clear from genetic studies in both Drosophila and mice that mechanisms that regulate cell proliferation during tissue growth play a crucial role in this process (Conlon and Raff, 1999; Oldham et al., 2000; Potter et al., 2001) . Here, we report the genetic characterization of the Drosophila homolog of C-terminal Src kinase. Our analyses of mutations in Drosophila CSK demonstrate a new role for CSK during development; the control of tissue size by regulation of cell proliferation.
The dcsk mutants display dramatic enlarged animal and tissue phenotypes. Examination of mutant imaginal discs by flow cytometry showed that dcsk mutant cells have a similar size to wild-type cells. Immunohistochemistry analysis of mutant eye discs revealed that loss of dcsk function does not disrupt apoptosis or differentiation. On the other hand, extra BrdU-labeled cells are observed in the mutant eye discs. Together, these results indicate that dcsk deregulates tissue size primarily by affecting cell proliferation during development.
Examination of cell proliferation in dcsk mutants reveals that dcsk affects cell cycle regulation. In the posterior region of the eye disc, dcsk mutant cells reenter the cell cycle from a G 0 state. This indicates that dcsk function is essential for maintaining cells in G 0 until the cells receive signals to be recruited into the developing ommatidia or die by apoptosis. Furthermore, examination of cycling cells in the wing imaginal discs by flow cytometry revealed that dCSK mutant cells exhibit a significant decrease in cells in G 0 /G 1 . This suggests that dCSK is normally involved in a mechanism that prevents cells from promiscuous reentry into the cell cycle from G 0 /G 1 .
Previous studies in mice have shown that the inability of cells to stop proliferating is associated with increased tissue and animal size. Mutations in the CDK inhibitors, p27/Kip1 and p18/INK in mice, cause up to a 30% increase in animal and tissue size due to excessive cell numbers in all organs (Kiyokawa et al., 1996; Nakayama et al., 1996) . Although Drosophila lats clearly regulates tissue and animal size by controlling cell proliferation, the role of the mammalian Lats pathway in controlling organ size is less clear due to its involvement in other developmental processes. For example, homozygous Lats1 deficient mice are smaller than their wild-type siblings due to disruption of pituitary gland development. Therefore, it is not known whether mammalian Lats also play a role in organ size control. Similarly, although the PTEN tumor suppressor gene is involved in the regulation of organ size in Drosophila (Huang et al., 1999b) , the role of mammalian PTEN in organ size control was not revealed until conditional PTEN mouse knockouts in the brain were generated to show cell proliferation and organ size defects (Di Cristofano et al., 1998; Backman et al., 2001; Groszer et al., 2001; Li et al., 2002) . Similar conditional knockout experiments for Lats1 and/or Lats2 will be needed to address whether the Lats genes regulate organ size during mammalian development.
dCSK and LATS function together in size control
Genetic modifier screens in Drosophila have provided a powerful tool in the dissection of signal transduction pathways (Artavanis-Tsakonas et al., 1995; Rubin et al., 1997; Thomas and Wassarman, 1999) . We performed a dosage-sensitive genetic modifier screen to identify components of the lats-signaling pathway and identified dcsk as one of the strongest lats-interacting genes recovered from the screen. We show synergistic, dosage-sensitive interactions between dcsk and lats, which occur in a reciprocal manner in multiple tissues. Removing one copy of the dcsk gene dominantly suppresses lats overexpression phenotypes and dominantly enhances lats loss-of-function phenotypes. The enhanced phenotypes are similar to more severe lats homozygous phenotypes, indicating that dcsk and lats interact synergistically. Furthermore, the close functional relationship between dcsk and lats is underscored by the haplo-insufficient genetic interaction between dcsk and lats. While either dcsk or lats heterozygous animals (dcsk/ þ or lats/ þ ) are phenotypically wild type, double heterozygous animals (dcsk/ þ ; lats/ þ ) are semilethal and display overproliferation defects. Such dose-sensitive interactions are very specific and often reflect physical interactions between the proteins that are encoded by the interacting genes. Indeed, biochemical experiment shows that dCSK phosphorylates a conserved C-terminal residue in LATS, and is consistent with the genetic epistasis relationship observed between dcsk and lats. Together, these results indicate that dcsk and lats function cooperatively in regulating tissue size by controlling cell proliferation during Drosophila development.
Most of the studies on mammalian CSK characterized its relationship with SFK. There are two SFK members (Src64 and Src42) in the Drosophila genome (Hoffmann et al., 1983; Simon et al., 1985; Takahashi et al., 1996) . Mutations in Src64 result in ovarial ring canal defects and reduced fertility Guarnieri et al., 1998) , while mutations in Src42 cause embryonic lethality (Lu and Li, 1999) . Overexpression of both Src64 and Src42 in the developing photoreceptor precursors results in supernumerary R7 cells Lu and Li, 1999) . It is not known whether dCSK also regulates the activity Src in Drosophila. The fact that overexpression of lats only partially rescues dcsk mutant phenotypes (Figure 6j) suggests that dCSK has other downstream targets in vivo, such as Src42 (Figure 6b) . Future experiments in which the Src homologs are expressed in dcsk mutants would help to define the relationship between dCSK and the Drosophila Src homologs further.
Studies in mammalian systems have shown that CSK has SFK-independent functions (Bergman et al., 1995; Lowry et al., 2002) . One recent example used SFKdeficient cells to show that CSK links G protein signaling to the actin cytoskeleton independent of SFK activity (Lowry et al., 2002) . Indeed, CSK has been shown to be associated with or phosphorylate a number of other downstream molecules (Autero et al., 1994; Hildebrand et al., 1995; Cloutier and Veillette, 1996; Tremblay et al., 1996) . Our results indicate that Drosophila LATS is also a target of dCSK. The Cterminal dCSK phosphorylation site is conserved in other LATS homologs, suggesting that mammalian LATS molecules may also be substrates of CSK. Interestingly, Pinna and colleagues have defined the optimal peptide substrates for mammalian CSK (Ruzzene et al., 1997) . This predicts that the C-terminal tyrosine motifs of the mammalian LATS molecules would be better CSK substrates than Src.
Recent studies have shown that csk homologs are downregulated in a number of human cancers, such as colorectal and hepatocellular carcinoma (Masaki et al., 1999; Bougeret et al., 2001; Cam et al., 2001) . Targeted disruption of csk in mice result in embryonic lethality with developmental defects in multiple tissues (Imamoto and Soriano, 1993; Nada et al., 1993) . However, the role of mammalian CSK in the regulation of cell proliferation during normal development or tumorigenesis is unknown. The conservation between the fly and mammalian CSK and LATS homologs suggests that these molecules could also be involved in the regulation of cell proliferation and tissue size in mammals. The characterization of lats, dcsk as well as the other interacting genes provides an excellent opportunity to use Drosophila as a model to investigate further as to how signaling processes coordinate cell proliferation with tissue size control.
Method
Drosophila genetics
Crosses were performed according to standard procedures at 251C. The screen for dominant modifiers of GMR-lats will be described in detail elsewhere. To isolate additional alleles of dcsk, irradiated yw; dcsk flik / TM6B males (4000 rad) were crossed to yw; TM6B/TM3 females. 80 000 F1 progeny were screened for loss of eye pigmentation and yielded 13 dcsk alleles. Rescue experiments using the hs-dcsk, hs-lats, or hs-latsY1098F transgenes were performed by 1-h heat shock at 371C for every 24 h. At least five independent transgenic lines were used for rescue of lats null and hypomorphic phenotypes. At least 200 progeny were scored for rescue of the dcsk flik or lats P1 pupal phenotypes. Behavioral features were not examined. The dcsk flik mutant phenotype was suppressed by the hs-lats transgene at 251C.
Histology and flow cytometry
Fixation, antibody staining, and scanning electron microscopy were performed using standard methods (Tomlinson and Ready, 1987; Kimmel et al., 1990) . BrdU incorporation was performed as described (Huang et al., 1999b) . Mouse monoclonal Anti-BrdU (Beckton Dickinson) and rat monoclonal Anti-ELAV antibodies (Developmental Hybridoma Bank) were used at 1 : 100 and 1 : 20 dilution, respectively. TUNEL labeling was performed using a Boehringer Mannheim kit. Eye discs from pGMR-hid larvae were used as positive controls. Flow cytometry experiments were performed on yw hsFLP; FRT82 dcsk flik /FRT82 Ubi-GFP wing discs as described (Potter et al., 2001) . Morphometric and statistical analyses were performed as described (Potter et al., 2001 ).
Molecular biology
DNA flanking the P[w þ ]-element was recovered by plasmid rescue. A 6-kb R1/Bam genomic clone spanning the P-element insertion was used to screen an eye disc cDNA library. A full-length 3.7 kb dcsk-L cDNA was cloned into the Not1/Stu1 site of pCaSpeR-hs for transformation (Rubin and Spradling, 1982) . Phylogenetic analysis was performed using the Clustal method in the MegAlign 4.03 program (DNASTAR Inc.), To generate GST-fusion proteins, the ORF of dcsk was amplified by PCR and cloned into pGex4T1. The 1.4-kb RV/RI fragment of Lats and 1.6 kb R1/ Xho1 fragment of Src42 were cloned into pGex4T2 (Pharmacia). Site-directed mutagenesis was used to generate mis-sense mutations. The GST-fusion proteins were produced in BL21 bacteria and purified according to the manufacturer's instructions. The kinase assays were performed as described (Bougeret et al., 1993) . Equal amounts of GST-fusion proteins (100 ng) were loaded in each lane and checked by Coomasie Blue staining.
